Antidiabetic and antioxidant effects of oleanolic acid from Ligustrum lucidum Ait in alloxan-induced diabetic rats

Phytotherapy Research

Volumn 23, Issue 9, 2009, Pages 1257-1262

  Gao, Dawei ^a   Li, Qingwang ^a,b   Li, Ying ^a   Liu, Zhihua ^b   Fan, Yusheng ^b   Liu, Zhiwei ^a   Zhao, Hongwei ^a   Li, Jian ^a   Han, Zengsheng ^a  

^a YANSHAN UNIVERSITY   (China)

^b NORTHWEST A F UNIVERSITY   (China)

Author keywords

Antioxidant ability; Hypoglycemic effect; Hypolipidemic effect; Ligustrum lucidum Ait; Oleanolic acid

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALLOXAN; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; GLUTATHIONE PEROXIDASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; OLEANOLIC ACID; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG MEGADOSE; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HYPOLIPEMIA; KIDNEY; LIGUSTRUM; LIGUSTRUM LUCIDUM; LIVER; LIVER FUNCTION; LIVER PROTECTION; LOW DRUG DOSE; NONHUMAN; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ALLOXAN; ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; CHOLESTEROL; DIABETES MELLITUS, EXPERIMENTAL; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; LIGUSTRUM; OLEANOLIC ACID; PHYTOTHERAPY; RATS; RATS, WISTAR; TRIGLYCERIDES;

LIGUSTRUM LUCIDUM; RATTUS;

EID: 69749127035     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2603     Document Type: Article

References (32)

1. Aida S. 1993. Alkaline phosphatase isoenzyme activities in rheumatoid arthritis: hepatobiliary enzyme dissociation and relation to disease activity. Ann Rheum Dis J 52: 511-516. (Pubitemid 23227215)
2. Aksoy N, Vural H, Sabuncu T, Aksoy S. 2003. Effects of melatonin on oxidative-antioxidative status of tissues in streptozotocininduced diabetic rats. Cell Biochem Funct 21: 121-125. (Pubitemid 36597178)
3. Aragno M, Mastrocola R, Catalano MG, Brignardello E, Danni O, Boccuzzi G. 2004. Oxidative stress impairs skeletal muscle repair in diabetic rats. Diabetes 53: 1082-1088. (Pubitemid 38436622)
4. Bonnefont-Rousselot D, Bastard JP, Jaudon MC, Delattre J. 2000. Consequences of the diabetic status on the oxidant/antioxidant balance. Diabetes Metab 26: 163-176. (Pubitemid 30435761)
5. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
6. El-Demerdash FM, Yousef MI, Abou El-Naga NI. 2005. Biochemical study on the hypoglycemic effects of onion and garlic in alloxan-induced diabetic rats. Food Chem Toxicol 43: 57-63. (Pubitemid 39575733)
7. Fuliang HU, Hepburn HR, Xuan H, Chen M, Daya S, Radloff SE. 2005. Effects of propolis on blood glucose, blood lipid and free radicals in rats with diabetes mellitus. Pharmacol Res 51: 147-152. (Pubitemid 40040545)
8. Gao D, Li Q, Li Y et al. 2007. Antidiabetic potential of oleanolic acid from Ligustrum lucidum Ait. Can J Physiol Pharmacol 85: 1076-1083. (Pubitemid 351196406)
9. Girotti MW. 1985. Mechanisms of lipid peroxidation. Free Radic Biol Med 1: 87-95.
10. Hao ZQ, Hang BQ, Wang Y. 1992. Study of Ligustrum lucidum Ait on decreasing blood glucose. Chin Mater Med 17: 429-431.
11. Jia W, Gao W, Tang L. 2003. Antidiabetic herbal drugs officially approved in China. Phytother Res 17: 1127-1134. (Pubitemid 38057166)
12. Larcan A, Lambert H, Laprevote-Heully MC, Delorme N. 1979. Light and electron microscopic study of hepatic lesions in the course of hyperlactatemia in diabetic patients. Diabetes Metab 5: 103-112. (Pubitemid 9210624)
13. Mansour HA, Newairy AS, Yousef MI, Sheweita SA. 2002. Biochemical study on the effects of some Egyptian herbs in alloxan-induced diabetic rats. Toxicology 170: 221-228.
14. Ojewole JA. 2005. Antinociceptive, anti-inflammatory and antidiabetic effects of Bryophyllum pinnatum (Crassulaceae) leaf aqueous extract. J Ethnopharmacol 99: 13-19. (Pubitemid 40569395)
15. Ozsoy-Sacan O, Karabulut-Bulan O, Bolkent S, Yanardag R, Ozgey Y. 2004. Effects of chard ( Beta vulgaris L. var cicla) on the liver of the diabetic rats: a morphological and biochemical study. Biosci Biotechnol Biochem 68: 1640-1648. (Pubitemid 39260293)
16. Rabinovitch A, Suarez WL, Thomas PD, Strynadka K, Simpson I. 1992. Cytotoxic effects of cytokines on rat islets: evidence for involvement of free radicals and lipid peroxidation. Diabetologia 35: 409-413.
17. Reddy SV, Tiwari AK, Kumar US, Rao RJ, Rao JM. 2005. Free radical scavenging, enzyme inhibitory constituents from antidiabetic Ayurvedic medicinal plant Hydnocarpus wightiana Blume. Phytother Res 19: 277-281.
18. Reiter RJ. 1995. Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J 9: 526-533.
19. Robertson RP. 2004. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem 279: 42351-42354.
20. Sakatani T, Shirayama T, Suzaki Y et al. 2005. The association between cholesterol and mortality in heart failure. Comparison between patients with and without coronary artery disease. Int Heart J 46: 619-629.
21. Sharma SB, Nasir A, Prabhu KM, Murthy PS, Dev G. 2003. Hypoglycaemic and hypolipidemic effect of ethanolic extract of seeds of Eugenia jambolana in alloxan-induced diabetic rabbits. J Ethnopharmacol 85: 201-206. (Pubitemid 36294133)
22. Slatter DA, Bolton CH, Bailey AJ. 2000. The importance of lipidderived malondialdehyde in diabetes mellitus. Diabetologia. 43: 550-557. (Pubitemid 30322071)
23. Szkudelski T. 2001. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 50: 536-546. (Pubitemid 34087272)
24. Tanaka Y, Tran PO, Harmon J, Robertson RP. 2002. A role for glutathione peroxidase in protecting pancreatic β cells against oxidative stress in a model of glucose toxicity. Proc Natl Acad Sci USA 99: 12363-12368.
25. Taskinen MR. 2002. Diabetic dyslipidemia. Atheroscler Suppl 3: 47-51.
26. Trinder P. 1969. Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J Clin Pathol 22: 158-161.
27. Wang ZX, Gao BZ, Xu BY, Huang GC. 1991. Study on anti-mutagenic effect of Ligustrum lucidum Ait by drosophila test. Fujian J Tradit Chin Med 22: 50-51.
28. Wild S, Roglic G, Green A, Sicree R, King H. 2004. Global prevalence of diabetes estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047-1053. (Pubitemid 38579764)
29. Wohaieb SA, Godin DV. 1987. Alleviations in free radical tissue defense mechanisms in streptozotocin-induced diabetes in rats: Effects of insulin treatment. Diabetes 36: 1014-1018.
30. Xiang M, Gu ZL. 2002. Antitumor effect of Ligustrum lucidum Ait extract in vivo. Jiangsu Med J Clin Res 10: 13-15.
31. Xue F, Michels KB. 2007. Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr 86: s823-s835.
32. Yin YS, Yu CS. 1993. Study on chemical components and hepatoprotective properties of Ligustrum lucidum Ait. Chin Tradit Patent Med 15: 18-19.